Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

Michael Buch Tostesen, MD, Jan M. Norgaard, MD PhD, Mette Nørgaard, MD PhD, Bruno C. Medeiros, MD, Claus Werenberg Marcher, MD PhD, Ulrik Malthe Overgaard, MD, Claudia Schöllkopf, MD PhD, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MDPhD

Blood (2018) 132 (Supplement 1): 613.

https://doi.org/10.1182/blood-2018-99-110922

Published: 2018

Journal Articles

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Jakob Werner Hansen, MD, Morten Munk Johansen, MD, Maj Karoline Westman, MSc, Leonie Saft, MD PhD, Lene Dissing Sjö, MD PhD, Claus Werenberg Marcher, MD PhD, Mette Skov Holm, MD PhD, Marios Dimitriou, PhD, Mohsen Karimi, PhD, Klas Raaschou-Jensen, MD, Andreas Birkedal Glenthøj, MD PhD, Marianne Tang Severinsen, MD PhD, Eva Hellström-Lindberg, MD PhD, Mette Klarskov Andersen, MD DMSc, Kirsten Grønbæk, Professor, MD DMSc

Blood (2018) 132 (Supplement 1): 794.

https://doi.org/10.1182/blood-2018-99-110767

Published: 2018

Journal Articles

Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study

Lene Sofie Granfeldt Østgård, Mette Nørgaard, Bruno C. Medeiros, Marianne Tang Severinsen, Lone Smidstrup Friis, Claus Werenberg Marcher, Claudia Schoellkopf, Jan Maxwell Nørgaard

Blood (2018) 131 (24): 2730–2733.

https://doi.org/10.1182/blood-2017-11-814327

Published: 2018

Includes: Supplemental data

Journal Articles

Autoimmune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukemia: A National Population-Based Case-Control Study

Lene Sofie Granfeldt Østgård, MD PhD, Mette Nørgaard, MD PhD, Lars Pedersen, MSc, PhD, René Østgård, MD PhD, Ulrik Malthe Overgaard, MD, Claudia Schöllkopf, MD PhD, Marianne Tang Severinsen, MD PhD, Claus Werenberg Marcher, MD PhD, Morten Krogh Jensen, MD Dr.MDSci

Blood (2017) 130 (Supplement 1): 1304.

https://doi.org/10.1182/blood.V130.Suppl_1.1304.1304

Published: 2017

Journal Articles

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

Lene Sofie Granfeldt Østgård, MD PhD, Mette Nørgaard, MD PhD, Lars Pedersen, MSc, PhD, René Østgård, MD PhD, Marianne Tang Severinsen, MD PhD, Claudia Schöllkopf, MD PhD, Claus Werenberg Marcher, MD PhD, Lone Smidstrup Friis, MD PhD, Morten Krogh Jensen, MD Dr.Sc.

Blood (2017) 130 (Supplement 1): 1305.

https://doi.org/10.1182/blood.V130.Suppl_1.1305.1305

Published: 2017

Journal Articles

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Jorne Lionel Biccler, MSc, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MD PhD, Claus Werenberg Marcher, MD PhD, Peter Møller, MD, Claudia Schöllkopf, MD PhD, Lone Smidstrup Friis, MD PhD, Lasse Hjort Jakobsen, MSc, Tarec Christoffer El-Galaly, MD PhD, Jan M. Nørgaard, MD PhD

Blood (2017) 130 (Supplement 1): 2595.

https://doi.org/10.1182/blood.V130.Suppl_1.2595.2595

Published: 2017

NARROW

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study

Autoimmune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukemia: A National Population-Based Case-Control Study

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Email alerts

ASH Publications

American Society of Hematology

Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study

From Mild Cytopenia to Overt MDS and AML, the Mutational Profile Predicts Progression, but Not Survival

Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study

Autoimmune Diseases, Infections, Use of Antibiotics and the Risk of Acute Myeloid Leukemia: A National Population-Based Case-Control Study

Does NSAID Consumption Reduce the Risk of Acute Myeloid Leukemia? a National Population-Based Case-Control Study

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only